BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim SH, Lee EC, Shim JR, Park SJ. A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation. Liver Int. 2018;38:932-939. [PMID: 29053910 DOI: 10.1111/liv.13614] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Komagome M, Maki A, Nagata R, Masuda W, Kogure R, Mitsui T, Ninomiya R, Akamatsu N, Hasegawa K, Beck Y. Refractory Acute Antibody Mediated Rejection in Liver Transplant After Desensitization of Preformed Donor Specific Antibody-Validity of Bortezomib and Everolimus: A Case Report. Transplant Proc 2022;54:147-52. [PMID: 34974892 DOI: 10.1016/j.transproceed.2021.11.022] [Reference Citation Analysis]
2 Lee WC, Lee CF, Wu TH, Hung HC, Lee JC, Wang YC, Cheng CH, Wu TJ, Chou HS, Chan KM. Clinical Relevance of Isoagglutinin Rebound in Adult ABO-Incompatible Living Donor Liver Transplantation. J Pers Med 2021;11:1300. [PMID: 34945772 DOI: 10.3390/jpm11121300] [Reference Citation Analysis]
3 Lee B, Cho JY, Han HS, Yoon YS, Lee HW, Lee JS, Kim M, Choi Y. Long-term outcomes of emergency ABO-incompatible living donor liver transplantation using a modified desensitization protocol for highly sensitized patients with acute liver failure: A case report. Ann Hepatobiliary Pancreat Surg 2021;25:571-4. [PMID: 34845134 DOI: 10.14701/ahbps.2021.25.4.571] [Reference Citation Analysis]
4 Gan K, Li Z, Bao S, Fang Y, Wang T, Jin L, Ma M, Deng L, Peng Y, Li N, Zeng Z, Huang H. Clinical outcomes after ABO-incompatible liver transplantation: A systematic review and meta-analysis. Transpl Immunol 2021;69:101476. [PMID: 34601097 DOI: 10.1016/j.trim.2021.101476] [Reference Citation Analysis]
5 Natsuda K, Murokawa T, Lee KW, Yoon KC, Hong SK, Lee JM, Cho JH, Yi NJ, Suh KS. No diffuse intrahepatic biliary stricture after ABO-incompatible adult living donor liver transplantation using tailored rituximab-based desensitization protocol. Ann Transl Med 2021;9:30. [PMID: 33553323 DOI: 10.21037/atm-20-4703] [Reference Citation Analysis]
6 Takatsuki M, Eguchi S. ABO incompatibility as a possible risk factor for hepatic artery thrombosis in living donor liver transplantation. Ann Transl Med 2020;8:616. [PMID: 32566553 DOI: 10.21037/atm.2020.03.97] [Reference Citation Analysis]
7 Hibi T, Wei Chieh AK, Chi-Yan Chan A, Bhangui P. Current status of liver transplantation in Asia. Int J Surg 2020;82S:4-8. [PMID: 32535264 DOI: 10.1016/j.ijsu.2020.05.071] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
8 Goldaracena N, Barbas AS. Living donor liver transplantation. Curr Opin Organ Transplant. 2019;24:131-137. [PMID: 30694993 DOI: 10.1097/mot.0000000000000610] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Kim SH, Park J, Park SJ. Impact of ABO-incompatibility on hepatic artery thrombosis in living donor liver transplantation. Ann Transl Med 2019;7:625. [PMID: 31930026 DOI: 10.21037/atm.2019.11.34] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yadav DK, Hua YF, Bai X, Lou J, Que R, Gao S, Zhang Y, Wang J, Xie Q, Edoo MIA, Chutturghoon VK, Liang T. ABO-Incompatible Adult Living Donor Liver Transplantation in the Era of Rituximab: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract. 2019;2019:8589402. [PMID: 31285743 DOI: 10.1155/2019/8589402] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
11 Oh J, Kim JM. Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation. Clin Mol Hepatol 2020;26:1-6. [PMID: 30909688 DOI: 10.3350/cmh.2019.0023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
12 Shajahan S, Sasidharan ST, Surendran S, Shenoy V, Padma UD. Lessons learnt from living donor liver transplantation with ABO-incompatibility: A single-centre experience from southern India. Indian J Gastroenterol 2019;38:23-8. [PMID: 30848450 DOI: 10.1007/s12664-019-00933-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
13 Park J, Kim SH, Park SJ. ABO-incompatible living donor liver transplantation without plasma exchange on condition of urgency: Two case reports. Artif Organs 2019;43:607-8. [PMID: 30653697 DOI: 10.1111/aor.13406] [Reference Citation Analysis]
14 Kim SH, Lee EC, Na BG, Park SJ. Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation. Eur J Surg Oncol 2019;45:180-6. [PMID: 30243467 DOI: 10.1016/j.ejso.2018.07.066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Lan X, Zhang H, Li HY, Chen KF, Liu F, Wei YG, Li B. Feasibility of using marginal liver grafts in living donor liver transplantation. World J Gastroenterol 2018; 24(23): 2441-2456 [PMID: 29930466 DOI: 10.3748/wjg.v24.i23.2441] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]